Cargando…
Segmental Bile Duct-Targeted Liver Resection for Right-Sided Intrahepatic Stones
Hepatectomy is a safe and effective treatment for intrahepatic stones (IHSs). However, the resection plane for right-sided stones distributed within 2 segments is obstacle because of atrophy-hypertrophy complex formation of the liver and difficult dissection of segmental pedicle within the Glissonea...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617081/ https://www.ncbi.nlm.nih.gov/pubmed/26181559 http://dx.doi.org/10.1097/MD.0000000000001158 |
_version_ | 1782396760705990656 |
---|---|
author | Li, Shao-Qiang Hua, Yun-Peng Shen, Shun-Li Hu, Wen-Jie Peng, Bao-Gang Liang, Li-Jian |
author_facet | Li, Shao-Qiang Hua, Yun-Peng Shen, Shun-Li Hu, Wen-Jie Peng, Bao-Gang Liang, Li-Jian |
author_sort | Li, Shao-Qiang |
collection | PubMed |
description | Hepatectomy is a safe and effective treatment for intrahepatic stones (IHSs). However, the resection plane for right-sided stones distributed within 2 segments is obstacle because of atrophy-hypertrophy complex formation of the liver and difficult dissection of segmental pedicle within the Glissonean plate by conventional approach. Thus, we devised segmental bile duct-targeted liver resection (SBDLR) for IHS, which aimed at completely resection of diseased bile ducts. This study aimed to evaluate the outcomes of SBDLR for right-sided IHSs. From January 2009 to December 2013, 107 patients with IHS treated by SBDLR in our center were reviewed in a prospective database. Patients’ intermediate and long-term outcomes after SBDLR were analyzed. A total of 40 (37.4%) patients with localized right-sided stone and 67 (62.7%) patients with bilateral stones underwent SBDLR alone and SBDLR combined with left-sided hepatectomy, respectively. There was no hospital mortality of this cohort of patients. The postoperative morbidity was 35.5%. The mean intraoperative blood loss was 414 mL (range: 100–2500). Twenty-one (19.6%) patients needed red blood cells transfusion. The intermediate stone clearance rate was 94.4%; the final clearance rate reached 100% after subsequent postoperative cholangioscopic lithotomy. Only 2.8% patients developed stone recurrence in a median follow-up period of 38.3 months. SBDLR is a safe and effective treatment for right-sided IHS distributed within 2 segments. It is especially suitable for a subgroup of patients with bilateral stones whose right-sided stones are within 2 segments and bilateral liver resection is needed. |
format | Online Article Text |
id | pubmed-4617081 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-46170812015-10-27 Segmental Bile Duct-Targeted Liver Resection for Right-Sided Intrahepatic Stones Li, Shao-Qiang Hua, Yun-Peng Shen, Shun-Li Hu, Wen-Jie Peng, Bao-Gang Liang, Li-Jian Medicine (Baltimore) 7100 Hepatectomy is a safe and effective treatment for intrahepatic stones (IHSs). However, the resection plane for right-sided stones distributed within 2 segments is obstacle because of atrophy-hypertrophy complex formation of the liver and difficult dissection of segmental pedicle within the Glissonean plate by conventional approach. Thus, we devised segmental bile duct-targeted liver resection (SBDLR) for IHS, which aimed at completely resection of diseased bile ducts. This study aimed to evaluate the outcomes of SBDLR for right-sided IHSs. From January 2009 to December 2013, 107 patients with IHS treated by SBDLR in our center were reviewed in a prospective database. Patients’ intermediate and long-term outcomes after SBDLR were analyzed. A total of 40 (37.4%) patients with localized right-sided stone and 67 (62.7%) patients with bilateral stones underwent SBDLR alone and SBDLR combined with left-sided hepatectomy, respectively. There was no hospital mortality of this cohort of patients. The postoperative morbidity was 35.5%. The mean intraoperative blood loss was 414 mL (range: 100–2500). Twenty-one (19.6%) patients needed red blood cells transfusion. The intermediate stone clearance rate was 94.4%; the final clearance rate reached 100% after subsequent postoperative cholangioscopic lithotomy. Only 2.8% patients developed stone recurrence in a median follow-up period of 38.3 months. SBDLR is a safe and effective treatment for right-sided IHS distributed within 2 segments. It is especially suitable for a subgroup of patients with bilateral stones whose right-sided stones are within 2 segments and bilateral liver resection is needed. Wolters Kluwer Health 2015-07-17 /pmc/articles/PMC4617081/ /pubmed/26181559 http://dx.doi.org/10.1097/MD.0000000000001158 Text en Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by-nd/4.0 This is an open access article distributed under the Creative Commons Attribution-NoDerivatives License 4.0, which allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author. http://creativecommons.org/licenses/by-nd/4.0 |
spellingShingle | 7100 Li, Shao-Qiang Hua, Yun-Peng Shen, Shun-Li Hu, Wen-Jie Peng, Bao-Gang Liang, Li-Jian Segmental Bile Duct-Targeted Liver Resection for Right-Sided Intrahepatic Stones |
title | Segmental Bile Duct-Targeted Liver Resection for Right-Sided Intrahepatic Stones |
title_full | Segmental Bile Duct-Targeted Liver Resection for Right-Sided Intrahepatic Stones |
title_fullStr | Segmental Bile Duct-Targeted Liver Resection for Right-Sided Intrahepatic Stones |
title_full_unstemmed | Segmental Bile Duct-Targeted Liver Resection for Right-Sided Intrahepatic Stones |
title_short | Segmental Bile Duct-Targeted Liver Resection for Right-Sided Intrahepatic Stones |
title_sort | segmental bile duct-targeted liver resection for right-sided intrahepatic stones |
topic | 7100 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617081/ https://www.ncbi.nlm.nih.gov/pubmed/26181559 http://dx.doi.org/10.1097/MD.0000000000001158 |
work_keys_str_mv | AT lishaoqiang segmentalbileducttargetedliverresectionforrightsidedintrahepaticstones AT huayunpeng segmentalbileducttargetedliverresectionforrightsidedintrahepaticstones AT shenshunli segmentalbileducttargetedliverresectionforrightsidedintrahepaticstones AT huwenjie segmentalbileducttargetedliverresectionforrightsidedintrahepaticstones AT pengbaogang segmentalbileducttargetedliverresectionforrightsidedintrahepaticstones AT lianglijian segmentalbileducttargetedliverresectionforrightsidedintrahepaticstones |